Qiagen Germany

Qiagen Germany is owned by Qiagen.

Qiagen is one of the...

• Dax 40;
• Russell 3000;
• Stoxx 600.

Qiagen is a company listed under the stock ticker QGEN (DE).

View the org chart displaying its 2 main executives

Most searched biographies at Qiagen Germany

• Peter Bierbaum, Director Global Pricing and Business Analytics
• Thomas Deutschmann, Director, System Integration

Create your alert
to follow the executive moves at Qiagen Germany.

Qiagen has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Kristina Burow - Director at Scholar Rock

Learn more about the Biotechnology industry >

Press releases by Qiagen Germany

Social media about Qiagen Germany

• Qiagen Germany on Wikipedia, Google News & Yahoo Finance
• Qiagen Germany on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter Bierbaum

Call Qiagen Germany at +49...

View the org chart

Register to receive your alert

Report an error